Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The availability this week of Covid-19 vaccines in the nation's largest pharmacies will begin to change the trajectory of the pandemic across the US. As one of the federal government's national pharmacy partners for Covid-19 vaccinations, CVS Health is ready to continue our role in the coordinated response to the pandemic. And it is our responsibility -- and mission -- to make sure that vaccinations get distributed to those who need it the most.

CVS CEO: We must make sure vaccinations are available to communities that need them most

Before the opening bell on Feb. 16, CVS Health Corp. (NYSE:CVS) released fourth-quarter results that topped Wall Street's expectations.

CVS Health Shows Positive Outlook on 4th-Quarter and 2020 Results

CVS Health Corporation (CVS) CEO Karen Lynch on Q4 2020 Results - Earnings Call Transcript

The pandemic affects CVS Health's (CVS) fourth-quarter revenues in the Pharmacy Services segments as new therapy prescriptions reduce due to lower provider visits.

CVS Health (CVS) Q4 Earnings Top Estimates but Decline Y/Y

The shares of CVS Health Corp (NYSE:CVS) are down 3.2% at $71.89 at last check, despite the company's better-than-expected fourth-quarter earnings report.

CVS Health Stock Slips Despite Vaccination Tailwinds

CVS said on Tuesday (Feb. 16) that it is re-entering the Obamacare health plan market next year, and that its multi-pronged response to COVID has helped it grow sales and new consumer relationships. Citing the depth and breadth of the capabilities of its 300,000 employees and nearly 10,000 stores, CVS Health announced that its fourth-quarter […]

CVS Boosts Q4 Revenue With Focus On COVID Testing, Vaccines

CVS Health (CVS) has administered 15 million COVID tests at its pharmacies in the past year.

CVS Health (CVS) Benefiting from COVID Traffic

CVS Health Corp said on Tuesday it would return to selling individual health insurance plans that offer Affordable Care Act premium subsidies next year, saying the market had stabilized.

CVS Health says will reenter Obamacare market in January 2022

Covid-19 testing lifted results at CVS Health's pharmacy business, even as the pandemic weighed on nonprescription sales.

CVS Stock Is Climbing Because Covid-19 Testing Bolstered Earnings

CVS Health said it will re-enter the business of selling individual coverage under the Affordable Care Act next year.

CVS Will Return Aetna To Obamacare Market

CVS Health Corp. (NYSE: CVS) reported its financial results for the fiscal fourth quarter on Tuesday that topped analysts' estimates for profit and revenue. CVS Health shares, that you can learn to buy online here, were reported just under 1.5% down in premarket trading on Tuesday.

CVS Health tops Wall Street estimates in the fiscal fourth quarter

Foot traffic and front-of-store sales dropped at CVS stores because of the pandemic, but total prescription volume grew year over year.

CVS Health earnings top estimates as pharmacy sales get a lift from Covid testing, vaccines

Shares of CVS Health Corp. were little changed in premarket trading Tuesday, after the drugstore and health benefits company reported fourth-quarter profit and revenue that beat expectations. Net income fell to $973 million, or 74 cents a share, from $1.75 billion, or $1.34 a share, in the year-ago period.

CVS Health beats profit, revenue expectations, as it has administered more than 3 million COVID-19 vaccines

WOONSOCKET, R.I., Feb. 16, 2021 /PRNewswire/ -- Full Year and Fourth Quarter Highlights: Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year Full year and fourth quarter GAAP diluted earnings per share from continuing operations of $5.47 and $0.75 Full...

CVS Health Reports Fourth Quarter And Full-Year 2020 Results And Provides 2021 Full Year Guidance

Mobile TeleSystems

SSR Mining

U.S. Bancorp

Stock market plunges are inevitable, so be ready to go bargain hunting.

4 Value Stocks to Buy if the Stock Market Crashes

CVS Health (NYSE:CVS) unveils its next round of earnings this Tuesday, February 16. Here is Benzinga's everything-that-matters guide for the earnings announcement.

CVS Health's Earnings: A Preview

Baidu

Roku

Shopify

Walmart

Applied Materials

Deere & Company

Palantir Technologies

Twilio

Here, 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week.

Baidu, CVS, Roku, Shopify, Walmart and More Major Earnings Coming This Week

Walgreens

The vaccine rollout will test CVS and Walgreens' commitment to expanding health-care access in Black and Hispanic communities.

Covid vaccine rollout gives CVS, Walgreens a chance to bring health care to communities of color

We were reasonably bullish on CVS when it was at lows a few months ago, and preferred it clearly over Walgreens for several business and financial reasons. These reasons, especially their Aetna data sink, seem to explain a remarkable phenomenon: Machine Learning profiles CVS' business the same as Microsoft and Amazon.

Big Data Shows That CVS Health Belongs With Ecommerce And Tech

Sabre

No earnings reports are scheduled for release after markets close Friday, and no earnings are scheduled for release on Monday, February 15, when markets will be closed for the Presidents Day holiday.

Earnings Previews: Palantir, Sabre, CVS

Through November and December, the resurgence of new COVID-19 cases might have resulted in more COVID-19 tests conducts by CVS Health (CVS).

Is a Beat in the Cards for CVS Health (CVS) in Q4 Earnings?

Apple

American Well Corporation

Brookfield Renewable Partners

Ford Motor Company

Livent Corp

Ocean Power Technologies

AT&T

While you can chase the latest fads on Wall Street, these stocks for beginners provide more sustainable opportunities. The post 8 Stocks to Buy for Beginners in a Hot Market appeared first on InvestorPlace.

8 Stocks to Buy for Beginners in a Hot Market

WOONSOCKET, R.I., Feb. 2, 2021 /PRNewswire/ -- Building on the company's comprehensive efforts to help slow the spread of the virus, CVS Health (NYSE: CVS) will begin to administer COVID-19 vaccines to eligible populations on Thursday, February 11 at 17 CVS Pharmacy locations across South...

CVS Health to Administer COVID-19 Vaccines at 17 Pharmacy Locations in South Carolina as Part of Multi-State Activation

WOONSOCKET, R.I., Feb. 2, 2021 /PRNewswire/ -- Building on the company's comprehensive efforts to help slow the spread of the virus, CVS Health (NYSE: CVS) will begin to administer COVID-19 vaccines to eligible populations on Thursday, February 11 at 28 CVS Pharmacy locations across...

CVS Health to Administer COVID-19 Vaccines at 28 Pharmacy Locations in Virginia as Part of Multi-State Activation

WOONSOCKET, R.I., Feb. 2, 2021 /PRNewswire/ -- Building on the company's comprehensive efforts to help slow the spread of the virus, CVS Health (NYSE: CVS) will begin to administer COVID-19 vaccines to eligible populations on Thursday, February 11 at 32 CVS Pharmacy locations across New...

News for CVS Health Stock (CVS)